Lincoln Park Biosciences
Scottsdale, US · Founded 2022 · Illinois LLC
Founders & leadership
MM
Marcus MamolenNamed on SEC filing
JT
Jonathan Tessmar-BellNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2022
▶$400KraisedJun 2022 · 2 investors · ManufacturingRule 506(b)
▶$400KraisedJun 2022 · 2 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Marcus MamolenExecutive Officer
- Jonathan Tessmar-BellExecutive Officer
- Offering amount
- $400K
- Amount sold
- $400K
- Minimum investment
- $200K
- First sale
- Jun 2022
- Incorporated
- Limited Liability Company, Illinois, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Lincoln Park Biosciences raised?
- Lincoln Park Biosciences has disclosed $400K raised across 1 round.
- Where is Lincoln Park Biosciences headquartered?
- Lincoln Park Biosciences is headquartered in Scottsdale, US.